Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04083339 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy
A Phase 3 study of Diabetic Cardiomyopathies, sponsored by Applied Therapeutics.
- Active
- Registry status
- Phase 3
- Development phase
- 675
- Enrollment target
- 20
- Study locations
NCT04083339 is a Phase 3 study of Diabetic Cardiomyopathies that is active but no longer recruiting, run by Applied Therapeutics. The registered enrollment target is 675 participants. The trial reports 20 study locations across 10 states.
The verdict
NCT04083339, a Phase 3 study of Diabetic Cardiomyopathies, is active but no longer recruiting, sponsored by Applied Therapeutics.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 675 participants
- Enrollment target
- 20
- Study locations
Study Summary
This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic Cardiomyopathy at high risk of progression to overt heart failure.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG AT-001
Study Locations (20)
California
- Westside Medical Associates of Los Angeles - Beverly Hills
- University of California, San Diego (UCSD) - La Jolla
- Clinical Trials Research - Lincoln
- University of California - Irvine Medical Center - Orange
- Metabolic Institute of America - Tarzana
- Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center - Torrance
Florida
- ALL Medical Research, LLC - Cooper City
- New Generation of Medical Research - Hialeah
- Broward Research Center - Pembroke Pines
- Progressive Medical Research - Port Orange
New York
- Chear Center LLC - The Bronx
- Montefiore Medical Center - The Bronx
Ohio
- Cleveland Clinic - Cleveland
- Remington Davis, Inc. - Columbus
Illinois
- UnityPoint Health - Methodist Hospital - Peoria
Massachusetts
- Brigham and Women's Hospital - Boston
Mississippi
- Universty of Mississippi Medical Center - Jackson
Missouri
- St. Louis Heart and Vascular Cardiology - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 675 participants |
| Start Date | 2019-09-20 |
| Est. Completion | 2025-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04083339
The ClinicalTrials.gov registry entry for NCT04083339 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 675 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Applied Therapeutics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Cardiomyopathies appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04083339 reports 20 study locations spanning 10 distinct geographic areas - top geographies include California, Florida, New York.
Frequently Asked Questions
What is clinical trial NCT04083339 about?
NCT04083339 is a clinical study titled "Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy". This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic Cardiomyopathy at high risk of progression to overt heart failure.
What is the current status of trial NCT04083339?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 675 participants. The study started on 2019-09-20. Estimated completion is 2025-12.
What conditions does trial NCT04083339 study?
This clinical trial studies the following conditions: Diabetic Cardiomyopathies.
What interventions are being tested in trial NCT04083339?
The interventions under investigation include: Placebo (DRUG), AT-001 (DRUG).
Who is sponsoring clinical trial NCT04083339?
This trial is sponsored by Applied Therapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04083339 being conducted?
This trial has 20 study locations across California, Florida, Illinois, Massachusetts, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Cardiomyopathies
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.